Name:
EAST: AFNET
Description:
EAST: AFNET
Thumbnail URL:
https://cadmoremediastorage.blob.core.windows.net/b90e8c10-9e2b-4e44-a202-c3403e18d250/thumbnails/b90e8c10-9e2b-4e44-a202-c3403e18d250.jpeg?sv=2019-02-02&sr=c&sig=L2bDhuLj%2BXFOYk0VeTxdPSuHccZAn8C8E%2FhxekxHNzw%3D&st=2024-12-21T13%3A19%3A16Z&se=2024-12-21T17%3A24%3A16Z&sp=r
Duration:
T00H02M52S
Embed URL:
https://stream.cadmore.media/player/b90e8c10-9e2b-4e44-a202-c3403e18d250
Content URL:
https://cadmoreoriginalmedia.blob.core.windows.net/b90e8c10-9e2b-4e44-a202-c3403e18d250/18778966.mp3?sv=2019-02-02&sr=c&sig=wSHybQJVCFozHrdrBNh59uHtpLLe%2BM5Pl6bvQ%2FrBzJE%3D&st=2024-12-21T13%3A19%3A16Z&se=2024-12-21T15%3A24%3A16Z&sp=r
Upload Date:
2022-02-28T00:00:00.0000000
Transcript:
Language: EN.
Segment:0 .
>> Practice Impact Extra podcasts are derived from Hurst's, the Heart Board Review and other online resources available only through AccessCardiology.com. >> More than three million Americans are diagnosed with atrial fibrillation. Many studies addressing treatment options are published. Still, what is the best treatment, is it rhythm or rate control, and that stills remains somewhat controversial. [ Music ] >> Hi. Dr. Bernie here, and welcome to Practice Impact Extra.
During the past several years several trials assessed, in patients with atrial fibrillation, rhythm control as it relates to medical and ablation comparisons. The EAST-AFNET trial was an important trial assessing rhythm control strategy compared to rate control and usual care. The trial randomized 1395 patients to rhythm control, and 1394 patients to usual care.
Patients with atrial fibrillation diagnosis with one year, with many enrolled within 36 days of the initial diagnosis of atrial fibrillation, were enrolled. The 1395 patients randomized to the rhythm control group were evaluated and followed for the primary outcome of cardiovascular death, stroke, hospitalization for heart failure, or acute coronary syndrome. So what were the results at five years?
Sinus rhythm was maintained in 82 percent of the rhythm control patient, versus 60 percent of those in the usual care group. Cardiovascular death, stroke, hospitalization for heart failure and acute coronary syndrome were less in the rhythm control group. Adverse events that all caused mortality was also less. They concluded that rhythm control strategy is superior to usual care in improving cardiovascular outcomes at five years among patients with a recent diagnosis of atrial fibrillation.
My thoughts? I believe this is an important study that tells me atrial fibrillation is not good for you. Early treatment through rhythm control strategy has value in recent atrial fibrillation diagnosis, and associated with concomitant cardiovascular conditions. Thank you again for joining me and see you next time on Practice Impact Extra. [ Music ] >> We hope you enjoyed this podcast from McGraw-Hill. Subscribers to AccessCardiology have instant access to over 25,000 pages of rich medical content, receive medical updates from trusted experts, and have access to other special features.
To subscribe or learn more, please visit AccessCardiology.com.